Model-predicted performance of second-trimester Down syndrome screening with sonographic prenasal thickness
Javier Miguelez1, Miki Moskovitch, Howard Cuckle
1Department of Obstetrics and Gynecology, University of São Paulo, São Paulo, Brazil.
Summary
Second-trimester prenatal screening using sonographic prenasal thickness (PT) measurement shows promising detection rates for Down syndrome. Combining PT with other markers, including serum tests and additional sonographic measurements, significantly enhances detection performance.
Area of Science:
- Prenatal diagnostics
- Medical imaging
- Genetics
Background:
- Second-trimester screening is crucial for detecting fetal abnormalities.
- Prenatal thickness (PT) is a sonographic marker used in fetal assessments.
- Accurate estimation of Down syndrome detection and false-positive rates is essential for effective screening.
Purpose of the Study:
- To estimate Down syndrome detection and false-positive rates using second-trimester sonographic prenasal thickness (PT) measurement.
- To evaluate the effectiveness of PT alone and in combination with other markers for Down syndrome screening.
Main Methods:
- Multivariate log Gaussian modeling was employed for data analysis.
- Prenatal thickness (PT) distribution parameters were derived from 105 Down syndrome and 1385 unaffected pregnancies.
- Data from new and previously published series were combined for robust parameter estimation.
Main Results:
- A log Gaussian model accurately fitted PT values in both Down syndrome and unaffected pregnancies.
- Prenatal thickness (PT) alone predicted detection rates of 35%, 51%, and 60% for 1%, 3%, and 5% false-positive rates, respectively.
- Combining PT with serum markers or additional sonographic markers (nasal bone length, nuchal skin fold) significantly improved detection rates.
Conclusions:
- Second-trimester screening incorporating sonographic PT and serum markers is predicted to achieve high Down syndrome detection rates.
- The addition of further sonographic markers can lead to performance comparable to first-trimester screening protocols.

